MeSH tree: D02
Antimicrobial resistance in children is rising globally and will worsen over the next decade, threatening the effectiveness of life-saving antibiotics, according to the world's first monitoring platform. The study, led by ...
11 hours ago
0
5
Joint replacements are among the most common surgeries worldwide, and preventing blood clots is critical to recovery. A Dalhousie-led study published this month—one of the most robust of its kind to date—found that a straightforward ...
12 hours ago
0
5
Scientists at Children's Medical Center Research Institute at UT Southwestern (CRI) have discovered why babies born with a rare inborn error of metabolism called GPT2 deficiency suffer from severe neurological impairment. ...
Jul 17, 2026
0
3
University of Manchester scientists have uncovered evidence that a buildup of a common body waste product in the brain could help drive two of the most devastating neurological diseases.
Jul 16, 2026
0
29
A study by researchers at Kent has revealed that the narcotic analgesic tapentadol has performance-enhancing effects on cyclists, making this drug a candidate for addition to the World Anti-Doping Agency's (WADA) list of ...
Jul 16, 2026
0
5
Crusty bread, fried meat and roasted coffee owe their characteristic taste and browning to chemical reactions that occur when foods are heated. In the so-called Maillard reaction, amino acids—the building blocks of proteins—react ...
Jul 16, 2026
0
10
Cambridge researchers have shown how commonly used sweeteners slow the growth of certain gut bacteria. One sweetener in particular—isosteviol—when combined with the antidepressant duloxetine, significantly impaired two important ...
Jul 16, 2026
0
25
The skull heals its cracks, the bruises fade, the swelling subsides and the bleeding stops. From the outside, a traumatic blow to the head, whether from a battlefield blast, car crash or even a tackle gone wrong, may seem ...
Jul 16, 2026
0
10
A new drug offers hope for people with hypertrophic cardiomyopathy, the world's most common inherited heart disease. The TEMPEST trial, led by University of Manchester researchers, tested the drug—called trientine—in 154 ...
Jul 16, 2026
0
4
In a new research report, scientists at Johns Hopkins University School of Medicine and Johns Hopkins Kimmel Cancer Center say they have found a potential therapeutic target that can boost the potency of a chemotherapy drug ...
Jul 15, 2026
0
4
